Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125910722 | 12591072 | 2 | F | 20151209 | 20151215 | 20160726 | 20160726 | PER | US-UNITED THERAPEUTICS-UNT-2015-015944 | UNITED THERAPEUTICS | 0.00 | A | F | Y | 0.00000 | 20160726 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125910722 | 12591072 | 1 | PS | REMODULIN | TREPROSTINIL | 1 | Subcutaneous | 0.0445 ?G/KG, CONTINUING | 21272 | .044 | UG/KG | INJECTION | |||||||
| 125910722 | 12591072 | 2 | SS | REMODULIN | TREPROSTINIL | 1 | Subcutaneous | 0.047 ?G/KG, CONTINUING | 21272 | .047 | UG/KG | INJECTION | |||||||
| 125910722 | 12591072 | 3 | SS | AMBRISENTAN | AMBRISENTAN | 1 | Oral | 10 MG,QD | 0 | 10 | MG | TABLET | QD | ||||||
| 125910722 | 12591072 | 4 | SS | ADCIRCA | TADALAFIL | 1 | Unknown | U | U | 0 | |||||||||
| 125910722 | 12591072 | 5 | C | XARELTO | RIVAROXABAN | 1 | Unknown | 0 | |||||||||||
| 125910722 | 12591072 | 6 | C | AMBIEN | ZOLPIDEM TARTRATE | 1 | Unknown | 0 | |||||||||||
| 125910722 | 12591072 | 7 | C | BUMETANIDE. | BUMETANIDE | 1 | Unknown | 0 | |||||||||||
| 125910722 | 12591072 | 8 | C | ASPIRIN /00002701/ | ASPIRIN | 1 | Unknown | 0 | |||||||||||
| 125910722 | 12591072 | 9 | C | LASIX | FUROSEMIDE | 1 | Unknown | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125910722 | 12591072 | 1 | Pulmonary arterial hypertension |
| 125910722 | 12591072 | 3 | Pulmonary arterial hypertension |
| 125910722 | 12591072 | 4 | Product used for unknown indication |
| 125910722 | 12591072 | 5 | Product used for unknown indication |
| 125910722 | 12591072 | 6 | Product used for unknown indication |
| 125910722 | 12591072 | 7 | Product used for unknown indication |
| 125910722 | 12591072 | 8 | Product used for unknown indication |
| 125910722 | 12591072 | 9 | Product used for unknown indication |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125910722 | 12591072 | Constipation | |
| 125910722 | 12591072 | Diarrhoea | |
| 125910722 | 12591072 | Nausea | |
| 125910722 | 12591072 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125910722 | 12591072 | 1 | 20150731 | 0 | ||
| 125910722 | 12591072 | 3 | 20141014 | 0 |